U.S. Army Medical Department
USAMRIID Banner

About USAMRIID

Scientific Publications

Business Opportunities

Employment

Education & Training

Biological Safety

Unified Culture Collection

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

>>  Home  >>  Scientific Publications  >>  2008

— 2008 —

Ahmed SA, Smith L, Toth S.  Issues in therapeutic development against botulinum neurotoxins (BONT).  Toxicon  2008 Jun 1, 51(Suppl. 1): 8

Ahmed S, Olson MA, Ludivico ML, Gilsdorf J, Smith LA.  Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.  Protein journal  Apr 2008, 27(3): 151-62

Asher LVSU, Wahl-Jensen V, Zimmerman M, Larsen T, Hooper JW.  Ultrastructural Pathology in Syrian Hamsters Experimentally Infected with Andes Hantavirus.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 667

Blow JA, Mores CN, Dyer J, Dohm DJ.  Viral nucleic acid stabilization by RNA extraction reagent.  Journal of virological methods  Jun 2008, 150(1-2): 41-4

Bozue J, Mou S, Moody K, van de Wetering C, Cote C, Bassett A, Fritz D, Worsham P.  Mutation of phoP in the Fully Virulent CO92 Strain of Yersinia pestis Affects Intracellular Survival in Macrophages and Virulence by Subcutaneous Challenge in a Mouse Model of Infection But Not Virulence by Aerosol Exposure.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 111

Bradfute SB, Warfield KL, Bavari S.  Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection.  Journal of immunology  Mar 15 2008, 180(6): 4058-66

Cote CK, DiMezzo TL, Banks DJ, France B, Bradley KA, Welkos SL.  Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.  Microbes and infection  May 2008, 10(6): 613-9

Cote CK, Bozue J, Moody KL, Dimezzo TL, Chapman CE, Welkos SL.  Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.  Microbiology (Reading, England)  Feb 2008, 154(Pt 2): 619-32

Dembek ZF.  Preparedness for a CBRNE event.  Joint Force Quarterly  2008, 51(4): 52-56

Foster CD, Hunter TC, Gibbs PH, Leffel EK.  Whole-body plethysmography in African green monkeys (Chlorocebus aethiops) with and without jackets.  Journal of the American Association for Laboratory Animal Science-JAALAS  Sep 2008, 47(5): 52-5

Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS.  Cellular immune response to Marburg virus infection in cynomolgus macaques.  Viral immunology  Sep 2008, 21(3): 355-63

Golden JW, Hooper JW.  Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.  Virology  Jul 20 2008, 377(1): 19-29

Golden JW, Josleyn MD, Hooper JW.  Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.  Vaccine  Jun 25 2008, 26(27-28): 3507-15

Groves SS, Turell MJ, Bailey CL, Morozov VN.  Rapid active assay for the detection of antibodies to West Nile virus in chickens.  American Journal of Tropical Medicine and Hygiene  Jan 2008, 78(1): 63-69

Heine H S, Bassett J, Miller L, Bassett A, Ivins B E, Lehoux D, Arhin F F, Parr T R.  Moeck G.  Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.  Antimicrobial agents and chemotherapy  Sep 2008, 52(9): 3350-7

Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ.  An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.  Vaccine  Aug 5 2008, 26(33): 4262-6

Hooper JW, Ferro AM, Wahl-Jensen V.  Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.  Journal of virology  Feb 2008, 82(3): 1332-8

Keener WK, Rivera VR, Cho CY, Hale ML, Garber EAE, Poli MA.  Identification of the RNA N-glycosidase activity of ricin in castor bean extracts by an electrochemiluminescence-based assay.  Analytical Biochemistry  Jul 1 2008, 378(1): 87-89

Kortepeter MG, Martin JW, Rusnak JM, Cieslak TJ, Warfield KL, Anderson EL, Ranadive MV.  Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit.  Emerging infectious diseases  Jun 2008, 14(6): 881-7

Krakauer T, Buckley M.  The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB.  Immunopharmacology and immunotoxicology  2008, 30(1): 163-79

Kumaran D, Rawat R, Ahmed SA, Swaminathan S.  Substrate binding mode and its implications on drug design for botulinum neurotoxin A.  PLos Pathog  2008 Sep 26, 4(9): e1000165

Larkin E, Bashirova A, Hale M, Stiles BG, Ulrich RG.  Human Monoclonal Antibodies against Staphylococcus aureus Enterotoxins: Potential Therapeutics?  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 44

Lebeda FJ, Adler M, Erickson K, Chushak Y.  Onset dynamics of type A botulinum neurotoxin-induced paralysis.  Journal of pharmacokinetics and pharmacodynamics  Jun 2008, 35(3): 251-67

Leffel EK, Twenhafel NA, Whitehouse CA.  Nosocomial infection of Serratia marcescens may induce a protective effect in monkeys exposed to Bacillus anthracis.  Journal of infection  Aug 2008, 57(2): 162-4

Little SF, Webster WM, Wilhelm H, Powell B, Enama J, Adamovicz JJ.  Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.  Biologicals Sep 2008, 36(5): 287-95  

McCall S, Vilensky JA, Gilman S, Taubenberger JK.  The relationship between encephalitis lethargica and influenza: a critical analysis.  Journal of neurovirology  May 2008, 14(3): 177-85

Mou S, Bozue J, Moody KS, Cote C, Bassett A, Worsham P.  Phage-Shock-Protein Response Is Required for Virulence of Yersinia pestis in Bubonic and Pneumonic Murine Plague Models.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 111-112

Nalca A, Hatkin JM, Garza NL, Nichols DK, Norris SW, Hruby DE, Jordan R.  Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model.  Antiviral research  Aug 2008, 79(2): 121-7

Nuss JE, Choksi KB, DeFord JH, Papaconstantinou J.  Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers.  Biochemical and biophysical research communications  Jan 11 2008, 365 (2): 355-61

O'Guinn ML, Klein TA, Lee JS, Kim HC, Baek LJ, Chong ST, Turell MJ, Burkett DA, Schuster A, Lee IY, Yi SH, Sames WJ, Song KJ, Song JW.  Ecological surveillance of small mammals at Firing Points 10 and 60, Gyeonggi Province, Republic of Korea, 2001-2005.  Journal of vector ecology  Dec 2008, 33(2): 370-84 (19263858)

Page JE, Murphy WJ.  Construction of radiation hybrid panels.  Methods in molecular biology  2008, 422:51-64

Parthasarathy N, DeShazer D, England M, Waag DM.  Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies (vol 56, pg 329, 2006).  Diagnostic Microbiology and Infectious Disease  Sept 2008, 62(1): 117

Peyser BD, Irizarry R, Spencer FA.  Statistical analysis of fitness data determined by TAG hybridization on microarrays.  Methods in molecular biology (Clifton, N.J.)  2008, 416:369-81

Raab R, Swietnicki W.  Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state.  Protein Expression and Purification Mar 2008, 58(1): 53-60

Rawat R, Ashraf Ahmed S, Swaminathan S.  High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.  Protein Expr Purif  2008 Aug, 60(2): 165-69

Rogers J, Schoepp RJ, Schroeder O, Clements TL, Holland TF, Li JQ, Li J, Lewis LM, Dirmeier RP, Frey GJ, Tan X, Wong K, Woodnutt G, Keller M, Reed DS, Kimmel BE, Tozer EC.  Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases.  Protein Engineering Design & Selection  Aug 2008, 21,(8): 495-505

Rossi CA, Ulrich M, Norris S, Reed DS, Pitt LM, Leffel EK.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.  Infection and immunity  Dec 2008, 76(12): 5790-801

Rozak D, Rozak A.  Simplicity, function, and legibility in an enhanced ambigraphic nucleic acid notation.  BioTechniques  May 2008, 44(6): 811-3

Saikh KU, Kissner TL, Nystrom S, Ruthel G, Ulrich RG.  Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers.  Clinical and Vaccine Immunology  Jan 2008, 15(1): 131-137 

Selby E, Hartman L, Whitehouse C, Coyne S, Jaissle J, Twenhafel N , Burke R, Kulesh D.  Rapid Real-Time PCR for Detection of Klebsiella pneumoniae and the rmpA Gene Target responsible for the Hypermucoviscosity Phenotype: Comparison with Culture for the Screening of African Green monkeys.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p, 720

Shipley MA, Minogue TD.  Evaluation of the Fujifilm QuickGene-Mini80 for Nucleic Acid Extraction and Subsequent Detection of Select Biothreat Agents.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 150

Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C.  Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.  Vaccine  Sep 19 2008, 26(40): 5177-81

Spurgers KB, Sharkey CM, Warfield KL, Bavari S.  Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses.  Antiviral research  Apr 2008, 78(1): 26-36

Swenson DL, Wang D, Luo Min, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD.  Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.  Clinical and vaccine immunology  Mar 2008, 15(3): 460-7

Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL, Hribar LJ, Pecor JE, Blow JA.  Potential for North American mosquitoes to transmit Rift Valley fever virus.  Journal of the American Mosquito Control Association  Dec 2008, 24(4): 502-7

Turell MJ, Linthicum KJ, Patrican LA, Davies FG, Kairo A, Bailey CL.  Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus.  Journal of medical entomology  Jan 2008, 45(1) 102-8

Turell MJ, O'Guinn ML, Dohm D, Zyzak M, Watts D, Fernandez R, Calampa C, Klein TA, Jones JW.  Susceptibility of Peruvian mosquitoes to eastern equine encephalitis virus.  Journal of medical entomology  Jul 2008, 45(4): 720-5

Turell MJ, Parker MD.  Protection of Hamsters by Venezuelan Equine Encephalitis Virus Candidate Vaccine V3526 against Lethal Challenge by Mosquito Bite and Intraperitoneal Injection.  American journal of tropical medicine and hygiene  Feb 2008, 78(2): 328-32

Turell MJ, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Klein TA.  Seasonal distribution, biology, and human attraction patterns of mosquitoes (Diptera: Culicidae) in a rural village and adjacent forested site near Iquitos, Peru.  Journal of medical entomology  Nov 2008, 45(6): 1165-72

Turell MJ, Whitehouse CA, Butler A, Baldwin C, Hottel H, Mores CN.  Assay for and replication of Karshi (mammalian tick-borne flavivirus group) virus in mice.  American journal of tropical medicine and hygiene  Feb 2008, 78(2): 344-7

Twenhafel NA, Whitehouse CA, Stevens EL, Hottel HE, Foster CD, Gamble S, Abbott S, Janda JM, Kreiselmeier N, Steele KE.  Multisystemic abscesses in African green monkeys (Chlorocebus aethiops) with invasive Klebsiella pneumoniae--identification of the hypermucoviscosity phenotype.  Veterinary pathology  Mar 2008, 45(2): 226-31

Waag DM, England MJ, Bolt CR, Williams JC.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.  Clinical and vaccine immunology  Oct 2008, 15(10): 1505-12

Welkos S, Norris S, Adamovicz J.  Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection.  Clinical and vaccine immunology  Jul 2008, 15(7): 1134-7

Worsham PL, Mou S, Cote C, Lockman H, Fritz D.  Cytotoxic Necrotizing Factor (CNF) Contributes to Virulence of Yersinia pseudotuberculosis Strain Yp III in a Murine Pneumonia Model.  Abstracts of the General Meeting of the American Society for Microbiology  2008, 108 p. 114


Return to top